Leptin, Obesity, and Leptin Resistance: Where Are We 25 Years Later?

Overview

Journal Nutrients

Date 2019 Nov 14

PMID 31717265

Citations 185

Authors

Andrea G Izquierdo

Ana B Crujeiras

Felipe F Casanueva

Marcos C Carreira

Affiliations

Soon will be listed here.

Abstract

Leptin, a hormone that is capable of effectively reducing food intake and body weight, was initially considered for use in the treatment of obesity. However, obese subjects have since been found to have high levels of circulating leptin and to be insensitive to the exogenous administration of leptin. The inability of leptin to exert its anorexigenic effects in obese individuals, and therefore, the lack of clinical utility of leptin in obesity, is defined as leptin resistance. This phenomenon has not yet been adequately characterized. Elucidation of the molecular mechanisms underlying leptin resistance is of vital importance for the application of leptin as an effective treatment for obesity. Leptin must cross the blood-brain barrier (BBB) to reach the hypothalamus and exert its anorexigenic functions. The mechanisms involved in leptin transportation across the blood-brain barrier continue to be unclear, thereby preventing the clinical application of leptin in the treatment of obesity. In recent years, new strategies have been developed to recover the response to leptin in obesity. We have summarized these strategies in this review.

Citing Articles

Association between body roundness index and sleep disorder: the mediating role of depression.

Gong H, Zhao Y BMC Psychiatry. 2025; 25(1):212.

PMID: 40055626 PMC: 11889924. DOI: 10.1186/s12888-025-06664-z.

Glucagon-Like Peptide 1 Receptor () Deficiency Does Not Appreciably Alter Airway Inflammation or Gut-Lung Microbiome Axis in a Mouse Model of Obese Allergic Airways Disease and Bariatric Surgery.

Kim Y, Ihrie V, Shi P, Ihrie M, Womble J, Meares A J Asthma Allergy. 2025; 18:285-305.

PMID: 40046174 PMC: 11880686. DOI: 10.2147/JAA.S478329.

Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management.

Barber T, Kabisch S, Pfeiffer A, Weickert M Metabolites. 2025; 15(2).

PMID: 39997710 PMC: 11857510. DOI: 10.3390/metabo15020085.

Obesity as a Disease: A Primer on Clinical and Physiological Insights.

Shah A, Davarci O, Chaftari P, Avenatti E Methodist Debakey Cardiovasc J. 2025; 21(2):4-13.

PMID: 39990758 PMC: 11843931. DOI: 10.14797/mdcvj.1515.

Revisiting the role of IL-27 in obesity-related metabolic diseases: safeguard or perturbation?.

An J, Fu D, Chen X, Guan C, Li L, Bai J Front Immunol. 2025; 15:1498288.

PMID: 39906735 PMC: 11792170. DOI: 10.3389/fimmu.2024.1498288.

References

Parks W, Frank D, Huff C, Renfrew Haft C, Martin J, Meng X . Sorting nexin 6, a novel SNX, interacts with the transforming growth factor-beta family of receptor serine-threonine kinases. J Biol Chem. 2001; 276(22):19332-9. DOI: 10.1074/jbc.M100606200. View

Banks W, Coon A, Robinson S, Moinuddin A, Shultz J, Nakaoke R . Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes. 2004; 53(5):1253-60. DOI: 10.2337/diabetes.53.5.1253. View

Bjornholm M, Munzberg H, Leshan R, Villanueva E, Bates S, Louis G . Mice lacking inhibitory leptin receptor signals are lean with normal endocrine function. J Clin Invest. 2007; 117(5):1354-60. PMC: 1838925. DOI: 10.1172/JCI30688. View

Schulz C, Paulus K, Johren O, Lehnert H . Intranasal leptin reduces appetite and induces weight loss in rats with diet-induced obesity (DIO). Endocrinology. 2011; 153(1):143-53. DOI: 10.1210/en.2011-1586. View

Barr V, Lane K, Taylor S . Subcellular localization and internalization of the four human leptin receptor isoforms. J Biol Chem. 1999; 274(30):21416-24. DOI: 10.1074/jbc.274.30.21416. View

Halaas J, Boozer C, Blair-West J, Fidahusein N, Denton D, Friedman J . Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci U S A. 1997; 94(16):8878-83. PMC: 23177. DOI: 10.1073/pnas.94.16.8878. View

Yi X, Yuan D, Farr S, Banks W, Poon C, Kabanov A . Pluronic modified leptin with increased systemic circulation, brain uptake and efficacy for treatment of obesity. J Control Release. 2014; 191:34-46. PMC: 4197010. DOI: 10.1016/j.jconrel.2014.05.044. View

Aronne L, Fujioka K, Aroda V, Chen K, Halseth A, Kesty N . Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study. J Clin Endocrinol Metab. 2007; 92(8):2977-83. DOI: 10.1210/jc.2006-2003. View

Doucet E, St Pierre S, Almeras N, Mauriege P, Richard D, Tremblay A . Changes in energy expenditure and substrate oxidation resulting from weight loss in obese men and women: is there an important contribution of leptin?. J Clin Endocrinol Metab. 2000; 85(4):1550-6. DOI: 10.1210/jcem.85.4.6500. View

10.

Ozcan L, Ergin A, Lu A, Chung J, Sarkar S, Nie D . Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 2009; 9(1):35-51. DOI: 10.1016/j.cmet.2008.12.004. View

11.

Faouzi M, Leshan R, Bjornholm M, Hennessey T, Jones J, Munzberg H . Differential accessibility of circulating leptin to individual hypothalamic sites. Endocrinology. 2007; 148(11):5414-23. DOI: 10.1210/en.2007-0655. View

12.

Dodd G, Decherf S, Loh K, Simonds S, Wiede F, Balland E . Leptin and insulin act on POMC neurons to promote the browning of white fat. Cell. 2015; 160(1-2):88-104. PMC: 4453004. DOI: 10.1016/j.cell.2014.12.022. View

13.

Couturier C, Sarkis C, Seron K, Belouzard S, Chen P, Lenain A . Silencing of OB-RGRP in mouse hypothalamic arcuate nucleus increases leptin receptor signaling and prevents diet-induced obesity. Proc Natl Acad Sci U S A. 2007; 104(49):19476-81. PMC: 2148314. DOI: 10.1073/pnas.0706671104. View

14.

Banno R, Zimmer D, De Jonghe B, Atienza M, Rak K, Yang W . PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance in mice. J Clin Invest. 2010; 120(3):720-34. PMC: 2827947. DOI: 10.1172/JCI39620. View

15.

Lantz K, Emeigh Hart S, Planey S, Roitman M, Ruiz-White I, Wolfe H . Inhibition of PTP1B by trodusquemine (MSI-1436) causes fat-specific weight loss in diet-induced obese mice. Obesity (Silver Spring). 2010; 18(8):1516-23. DOI: 10.1038/oby.2009.444. View

16.

van Heek M, Compton D, France C, Tedesco R, Fawzi A, Graziano M . Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest. 1997; 99(3):385-90. PMC: 507810. DOI: 10.1172/JCI119171. View

17.

Banks W, Clever C, Farrell C . Partial saturation and regional variation in the blood-to-brain transport of leptin in normal weight mice. Am J Physiol Endocrinol Metab. 2000; 278(6):E1158-65. DOI: 10.1152/ajpendo.2000.278.6.E1158. View

18.

Muller T, Sullivan L, Habegger K, Yi C, Kabra D, Grant E . Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21. J Pept Sci. 2012; 18(6):383-93. DOI: 10.1002/psc.2408. View

19.

Perlmutter D . Chemical chaperones: a pharmacological strategy for disorders of protein folding and trafficking. Pediatr Res. 2002; 52(6):832-6. DOI: 10.1203/00006450-200212000-00004. View

20.

Yan C, Yang Y, Saito K, Xu P, Wang C, Hinton Jr A . Meta-chlorophenylpiperazine enhances leptin sensitivity in diet-induced obese mice. Br J Pharmacol. 2015; 172(14):3510-21. PMC: 4507156. DOI: 10.1111/bph.13141. View